Vertex Provides an Update on the VX-880 Clinical Trial
Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around the clinical hold.
ATTD Conference Brings Together Top Minds in Diabetes Research
Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from April 27-30 in Barcelona.
Breakthrough T1D Elects Two Highly Engaged Volunteers to Lead International Board of Directors
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has named two longtime, highly engaged volunteers to lead its International Board of Directors as Chair and Vice Chair, effective July 1, 2022.
100, 100: Breakthrough T1D Research Leads to a New Class of Glucose-Lowering Agents
You’ve seen the ads: Victoza®. Ozempic®. Trulicity®. But did you know that these drugs came about, in part, because of type 1 diabetes research?
Marguerite “Peggy” Quirke Leaves $3.2 Million Bequest to Breakthrough T1D
Breakthrough T1D is grateful to Peggy Quirke, whose $3.2 million bequest will accelerate Breakthrough T1D's mission to find cures for type 1 diabetes (T1D).
100, 100: Genetically Engineered Human Insulin Created
In 1976, researchers set out to synthesize the human insulin gene and make human insulin, and Breakthrough T1D researchers had multiple hands in the biosynthesis of it.
More CGMs Now Covered by Medicare
In March 2022, Medicare beneficiaries became eligible for coverage for a greater number of CGMs than ever before. Due to a final rule issued on December 21, 2021 by the Centers for Medicare and Medicaid Services (CMS), any CGM that connects with an insulin pump or a standalone receiver will be covered by Medicare for […]
Insulin Affordability? Yes, Please: Breakthrough T1D Joins Civica to Make Low-Cost Insulin Available to All Americans
In conjunction with leading partners, Breakthrough T1D lends its support to Civica, to help combat a nationwide insulin affordability crisis.
Breakthrough T1D Statement: President’s Comments about Insulin Affordability During State of the Union
Breakthrough T1D is glad President Biden used the State of the Union to address the insulin affordability crisis, which has had devastating consequences in the diabetes community for far too long. Joshua Davis, the young man with type 1 diabetes who joined the First Lady in the gallery, was one of the Breakthrough T1D Children’s […]
Helping the Diabetes Community in Ukraine – 6/1 Update
Guide on how to support the diabetes community in Ukraine.
